Nan Li invests at the intersection of life sciences and computing as a co-founder and managing partner of Dimension. He previously led frontier-tech investing at Obvious Ventures and product, operations and finance at Gigwalk.
Nan Li invests at the intersection of life sciences and computing as a co-founder and managing partner of Dimension. He previously led frontier-tech investing at Obvious Ventures and product, operations and finance at Gigwalk.
Career
Nan Li studied at University of Michigan (BSE, Computer Science Engineering).
OTBoard Director at Odyssey Therapeutics from 2025-06 to Present
ABBoard Director at Aspect Biosystems from 2025-01 to Present
Co-Founder and Managing Partner at Dimension from 2022-04 to PresentABoard Director at Automata until Present
FBoard Director at Fiveonefour until Present
TBBoard Director at Tamarind Bio until Present
Investor at Obvious Ventures from 2015-03 to 2022-04Joined as a principal and was promoted to managing director in July 2018.
Investment Partner at Innovation Endeavors from 2013 to 2015GHead of Product, Operations and Finance at Gigwalk from 2012 to 2013
BCInvestor at Bain Capital Ventures from 2010 to 2012
B&Management Consultant at Bain & Company from 2008 to 2010
MProduct Manager, Windows Live at Microsoft from 2007 to 2007
Investing Announcements
Cosigns Received
Jacob KimmelCo-founder & CEO at NewLimit developing epigenetic reprogramming therapeutics for aging and age-related disease.
we’ve been privileged to work with them @newlimit
Chris GibsonCo-Founder and former CEO at Recursion
Zavain and Nan were ... a steadfast and trustworthy partner.
James JoaquinCo-Founder and Managing Director at Obvious Ventures
He has demonstrated a nose for finding amazing entrepreneurs putting frontier tech to work solving tough problems in big markets